; (II) the introductory wholesale acquisition cost; (III) the net average price realized by pharmacy benefit managers for such prescription drug provided to individuals in the United States, after accounting for any rebates or other payments from the manufacturer to the pharmacy benefit manager and from the pharmacy benefit manager to the manufacturer; (IV) the list price of such prescription drug charged to purchasers in each applicable prescription drug reference country; (V) the net price of such prescription drug, after accounting for discounts, rebates, or other financial considerations, charged to purchasers in each applicable prescription drug reference country; (VI) a description of all price changes of the prescription drug since the introductory wholesale acquisition cost